Revenue segments as reported by the company.

Beauty

Grooming

Health Care

Fabric & Home Care

Baby, Feminine & Family Care

Corporate

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Goodwill and indefinite-lived intangibles impairment charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Procter & Gamble

Old Spice is a brand of male grooming products encompassing deodorants and antiperspirants, shampoos, body washes, and soaps.

Old Spice

Crest is a brand of toothpaste and other oral hygiene products sold worldwide.

Crest

Tampax is a brand of tampon sold in over 100 countries.

Tampax

Tide

Braun AG, is a German consumer products company based in Kronberg. From 1984 until 2007, Braun was a wholly owned subsidiary of The Gillette Company, which had purchased a controlling interest in the company in 1967. Braun is now a wholly owned subsidiary of Procter & Gamble, which acquired Gillette in 2005. On 16 April 2012, De'Longhi bought perpetual rights to manufacture Braun branded products from Procter & Gamble in the small appliance segment. Procter & Gamble will continue to own the Braun brand.

Braun

Gillette is a brand of men's and women's safety razors and other personal care products including shaving supplies.

Gillette

Olay is a brand of beauty products focusing on skin care.

Olay

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Procter & Gamble reports strong Q3 performance and navigates challenges

Procter & Gamble delivered strong Q3 results, raising its guidance for organic sales growth and maintaining its outlook for core earnings per share growth. The company faces challenges related to sustained cost pressures, supply constraints, and volume recovery in certain regions. However, opportunities exist in travel retail reopening, innovation strategies, and continued resilience.

Procter & Gamble reports Q2 growth amid global challenges

Procter & Gamble's Q2 showed mixed results with strong U.S. sales but challenges in Greater China.
Guidance raised for organic sales growth, but significant headwinds persist from raw material costs and currency fluctuations.
Investments in brand superiority and supply chain optimization present growth opportunities.
Balancing input cost inflation and navigating market uncertainties remain key challenges.

Procter & Gamble reports robust Q3 results amidst global challenges

Procter & Gamble's Q3 performance reflects strong execution of strategies, leading to organic sales growth and margin improvement.
Despite challenges from costs and supply constraints, P&G's focus on innovation and market leadership positions it well for future growth.
Opportunities in China, Latin America, and Europe, along with continued productivity improvements, offer avenues for sustained growth and market expansion.
P&G's long-term approach to navigating challenges and serving stakeholders effectively underscores its resilience and commitment to sustainable growth.

Procter & Gamble posts robust Q4 earnings amidst market challenges

Procter & Gamble (PG) reported strong financial performance in Q4 2023 and fiscal year 2023, driven by organic sales growth and operational efficiency.
The company's strategic focus on innovation, market share growth, and cost management positions it well to navigate challenges and capitalize on opportunities.
Despite challenges in the China market and supply chain disruptions, P&G remains committed to driving growth, enhancing productivity, and delivering shareholder value.

Procter & Gamble reports strong Q1 results and outlines growth strategies

Procter & Gamble's Q1 performance reflects robust sales growth and financial strength.
While facing challenges in certain regions, the company remains focused on driving innovation and value creation.
Opportunities in commodity tailwinds and marketing investments position PG for continued growth.
Confidence in strategy and commitment to balanced growth underscore PG's resilience.

Procter & Gamble reports robust Q2 earnings amidst market challenges

Procter & Gamble's Q2 2024 earnings call showcased strong performance, emphasizing sales growth, margin improvement, and strategic focus on innovation. While facing challenges in key markets, P&G remains resilient and focused on overcoming obstacles to drive growth. The company's opportunities lie in maintaining sales growth, enhancing earnings, and strategic market decisions.

Procter & Gamble (PG) posts robust Q3 results, eyes innovation for growth

Procter & Gamble (PG) reported strong Q3 performance, highlighting growth in key markets and increased earnings. Despite challenges in China and the Middle East, the company remains focused on innovation and market growth to drive future success.

Procter & Gamble reports strong Q4 results, eyes innovation for growth

Procter & Gamble's Q4 performance showcases resilience and strategic focus amidst regional challenges. The company's emphasis on innovation, market growth, and consumer delight positions it well for sustained positive results and value creation.

Procter & Gamble reports 2% organic sales growth in Q1 2025

Procter & Gamble delivered steady organic sales growth, strong core earnings, and maintained guidance for fiscal year '25. Challenges in Greater China and Europe require attention, while opportunities in Latin America and shareholder value creation through dividends and stock repurchases are key focus areas.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Coca-Cola

Altria

Many Consumer Staples stocks pay dividends, providing a passive income stream and a cushion against the impacts of drawdowns. And these three stocks are no different, all currently yielding more than 2.5% annually.

Like Income? 3 Consumer Staples Stocks Worth a Look

CINCINNATI--(BUSINESS WIRE)--Jon R. Moeller, Chairman of the Board, President and Chief Executive Officer and Andre Schulten, Chief Financial Officer of The Procter & Gamble Company (NYSE:PG) will be featured speakers at the Consumer Analyst Group of New York Conference on Thursday, February 23, 2023, at 9:00 a.m. ET. Media and investors may access the live audio webcast at www.pginvestor.com beginning at 9:00 a.m. ET. The webcast will also be available for replay.

P&G to Webcast Presentation From the Consumer Analyst Group of New York Conference, February 23

Kroger

Second-annual scholarship program is "changing the game" for women in business, education and sports CINCINNATI , Feb. 15, 2023 /PRNewswire/ -- The Kroger Co. (NYSE: KR) and The Procter & Gamble Company (NYSE: PG) today announced the application period for its 2023 Game Changers Scholarship is now open. In its second year, 23 scholarships of $2,000 will be awarded to diverse female students pursuing a business-related, sciences, technical and/or liberal arts undergraduate degree or certificate.

Kroger and P&G Open Applications for the 2023 Game Changers Scholarship presented by The Kroger Foundation and Always® Brand

Agile Therapeutics

Appointment of Ernie De Paolantonio to Chief Financial Officer Further  Strengthens Leadership Team GRAND RAPIDS, Mich. , Feb. 15, 2023 /PRNewswire/ -- Corium Pharma Solutions, Inc. (CPSI), a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies for prescription drug and consumer products including transdermal modalities, has named Ernie De Paolantonio as Chief Financial Officer.

Corium Pharma Solutions Names Ernie De Paolantonio as Chief Financial Officer

Costco

Kellogg

Live Nation

Ralph Lauren

Tesla

Consumer staples and consumer discretionary have one thing in common: they affect consumers. In falling stock markets and weak economic climates, the term "consumer staples" became more familiar in the media.

Consumer Staples vs. Consumer Discretionary

Dominion Energy

Dollar General

General Mills

McDonald's

Although the new year seemingly got off to an encouragingly robust start, recent data suggests that investors should target viable stocks to buy for a slowing economy. At first, such a notion seems odd, particularly in light of the blowout jobs report for Jan. However, this dynamic also implies that more dollars chase after fewer goods – an inflationary scenario that the Federal Reserve hates.

7 Stocks Ready for a Slowing Economy

Caterpillar

Salesforce

Visa

We have narrowed our search to five blue-Chip (components of Dow) stocks with strong potential for 2023. These are: PG, V, CRM, CAT and KO.

5 Blue-Chip Stocks to Buy Despite Dow's Sluggish Start in 2023

Citigroup

Diageo

Jefferies Financial Group Inc

Kraft Heinz

If any investor has stood the test of time, it is Warren Buffett. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world.

Why the Highest Yielding Warren Buffett Stocks Are Still the Best 2023 Ideas

Genuine Parts

Illinois Tool Works

At a time when inflation remains an issue, geopolitical risks are rising and the threat of recession looms large, insisting on quality, safety and dividends when picking stocks is more important than ever. In this article, we will look at three Dividend Kings.

3 Dividend Kings to Buy for Safe Dividend Growth

Berry Petroleum Corp.

Celsius Holdings

Chevron

Disney

Enphase Energy

Home Depot

Lantronix

NIKE

Northern Oil and Gas

Two new Breakout Stocks for Week 7 with better than 10% short-term upside and one Dow 30 Picks. Average cumulative returns for 2023 are +26.6% YTD. This week no selections gained over 10% as the Momentum Gauges® recorded the largest drop since the December 5th negative signal and started an early negative signal.

MDA Breakout Stocks Week 7 - February 2023: High-Frequency Gainers To Give You An Edge

P&G (PG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -8.52% in 4 Weeks, Here's Why P&G (PG) Looks Ripe for a Turnaround

Appointments of Kevin Ostrander to Chief Business Officer and Dr. Niraj Vasisht to Chief Technology Officer Further Strengthen Leadership Team GRAND RAPIDS, Mich. , Feb. 9, 2023 /PRNewswire/ -- Corium Pharma Solutions, Inc. (CPSI), a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies for prescription drug and consumer products including transdermal modalities, has named Kevin Ostrander as Chief Business Officer and Dr. Niraj Vasisht as Chief Technology Officer.

Corium Pharma Solutions Names Two Industry Veterans to its Executive Team

Hershey

Lockheed Martin

NextEra Energy

PepsiCo

Philip Morris

UnitedHealth Group

With the economy and the stock market not fully out of the woods, my suggestion is to focus on the safest stocks at the moment. With the most recent statements from Federal Reserve Chairman Jerome Powell suggesting that interest rates will keep rising, and that a “Fed pivot” isn't just around the corner, the overall market's strong performance over the past month could give way to another broad market sell-off.

The 7 Safest Stocks You Can Buy in February 2023

JPMorgan Chase & Co

Here are three blue chip stocks to watch in the stock market this week.

3 Blue Chip Stocks To Watch In February 2023

Conagra Brands

Kimberly-Clark

ManpowerGroup

Marine Products

Robert Half Int.

Stanley Black & Decker

Earnings reports may be backward looking, but there are still many reasons investors should play close attention to what companies say in them, and why MarketWatch covers them so diligently every quarter.

This is the best way to understand where stocks are headed

Johnson & Johnson

They aren't quite the Dogs of the Dow, but these blue chips are limping into February.

Is It Time to Buy the Dow Jones' 3 Worst-Performing January Stocks?

These two Dow giants both look attractive today.

Better Buy: McDonald's vs. Procter & Gamble

Archer-Daniels-Midland Company

Allstate

After a sharp downturn in 2022, investors may be looking for high-risk, high-reward equities to bank on as opposed to boring stocks to buy and hold forever. I get it. As some of the hottest names get cheaper, a temptation exists to pick them up for pennies on the dollar.

7 Boring Stocks to Buy and Hold Forever

News for Procter & Gamble Stock (PG)